Cargando…
Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk
BACKGROUND: Chronological age is a prominent risk factor for many types of cancers including colorectal cancer (CRC). Yet, the risk of CRC varies substantially between individuals, even within the same age group, which may reflect heterogeneity in biological tissue aging between people. Epigenetic c...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942339/ https://www.ncbi.nlm.nih.gov/pubmed/31900199 http://dx.doi.org/10.1186/s13148-019-0801-3 |
_version_ | 1783484684250906624 |
---|---|
author | Wang, Ting Maden, Sean K. Luebeck, Georg E. Li, Christopher I. Newcomb, Polly A. Ulrich, Cornelia M. Joo, Ji-Hoon E. Buchanan, Daniel D. Milne, Roger L. Southey, Melissa C. Carter, Kelly T. Willbanks, Amber R. Luo, Yanxin Yu, Ming Grady, William M. |
author_facet | Wang, Ting Maden, Sean K. Luebeck, Georg E. Li, Christopher I. Newcomb, Polly A. Ulrich, Cornelia M. Joo, Ji-Hoon E. Buchanan, Daniel D. Milne, Roger L. Southey, Melissa C. Carter, Kelly T. Willbanks, Amber R. Luo, Yanxin Yu, Ming Grady, William M. |
author_sort | Wang, Ting |
collection | PubMed |
description | BACKGROUND: Chronological age is a prominent risk factor for many types of cancers including colorectal cancer (CRC). Yet, the risk of CRC varies substantially between individuals, even within the same age group, which may reflect heterogeneity in biological tissue aging between people. Epigenetic clocks based on DNA methylation are a useful measure of the biological aging process with the potential to serve as a biomarker of an individual’s susceptibility to age-related diseases such as CRC. METHODS: We conducted a genome-wide DNA methylation study on samples of normal colon mucosa (N = 334). Subjects were assigned to three cancer risk groups (low, medium, and high) based on their personal adenoma or cancer history. Using previously established epigenetic clocks (Hannum, Horvath, PhenoAge, and EpiTOC), we estimated the biological age of each sample and assessed for epigenetic age acceleration in the samples by regressing the estimated biological age on the individual’s chronological age. We compared the epigenetic age acceleration between different risk groups using a multivariate linear regression model with the adjustment for gender and cell-type fractions for each epigenetic clock. An epigenome-wide association study (EWAS) was performed to identify differential methylation changes associated with CRC risk. RESULTS: Each epigenetic clock was significantly correlated with the chronological age of the subjects, and the Horvath clock exhibited the strongest correlation in all risk groups (r > 0.8, p < 1 × 10(−30)). The PhenoAge clock (p = 0.0012) revealed epigenetic age deceleration in the high-risk group compared to the low-risk group. CONCLUSIONS: Among the four DNA methylation-based measures of biological age, the Horvath clock is the most accurate for estimating the chronological age of individuals. Individuals with a high risk for CRC have epigenetic age deceleration in their normal colons measured by the PhenoAge clock, which may reflect a dysfunctional epigenetic aging process. |
format | Online Article Text |
id | pubmed-6942339 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-69423392020-01-07 Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk Wang, Ting Maden, Sean K. Luebeck, Georg E. Li, Christopher I. Newcomb, Polly A. Ulrich, Cornelia M. Joo, Ji-Hoon E. Buchanan, Daniel D. Milne, Roger L. Southey, Melissa C. Carter, Kelly T. Willbanks, Amber R. Luo, Yanxin Yu, Ming Grady, William M. Clin Epigenetics Research BACKGROUND: Chronological age is a prominent risk factor for many types of cancers including colorectal cancer (CRC). Yet, the risk of CRC varies substantially between individuals, even within the same age group, which may reflect heterogeneity in biological tissue aging between people. Epigenetic clocks based on DNA methylation are a useful measure of the biological aging process with the potential to serve as a biomarker of an individual’s susceptibility to age-related diseases such as CRC. METHODS: We conducted a genome-wide DNA methylation study on samples of normal colon mucosa (N = 334). Subjects were assigned to three cancer risk groups (low, medium, and high) based on their personal adenoma or cancer history. Using previously established epigenetic clocks (Hannum, Horvath, PhenoAge, and EpiTOC), we estimated the biological age of each sample and assessed for epigenetic age acceleration in the samples by regressing the estimated biological age on the individual’s chronological age. We compared the epigenetic age acceleration between different risk groups using a multivariate linear regression model with the adjustment for gender and cell-type fractions for each epigenetic clock. An epigenome-wide association study (EWAS) was performed to identify differential methylation changes associated with CRC risk. RESULTS: Each epigenetic clock was significantly correlated with the chronological age of the subjects, and the Horvath clock exhibited the strongest correlation in all risk groups (r > 0.8, p < 1 × 10(−30)). The PhenoAge clock (p = 0.0012) revealed epigenetic age deceleration in the high-risk group compared to the low-risk group. CONCLUSIONS: Among the four DNA methylation-based measures of biological age, the Horvath clock is the most accurate for estimating the chronological age of individuals. Individuals with a high risk for CRC have epigenetic age deceleration in their normal colons measured by the PhenoAge clock, which may reflect a dysfunctional epigenetic aging process. BioMed Central 2020-01-03 /pmc/articles/PMC6942339/ /pubmed/31900199 http://dx.doi.org/10.1186/s13148-019-0801-3 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Wang, Ting Maden, Sean K. Luebeck, Georg E. Li, Christopher I. Newcomb, Polly A. Ulrich, Cornelia M. Joo, Ji-Hoon E. Buchanan, Daniel D. Milne, Roger L. Southey, Melissa C. Carter, Kelly T. Willbanks, Amber R. Luo, Yanxin Yu, Ming Grady, William M. Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk |
title | Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk |
title_full | Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk |
title_fullStr | Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk |
title_full_unstemmed | Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk |
title_short | Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk |
title_sort | dysfunctional epigenetic aging of the normal colon and colorectal cancer risk |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942339/ https://www.ncbi.nlm.nih.gov/pubmed/31900199 http://dx.doi.org/10.1186/s13148-019-0801-3 |
work_keys_str_mv | AT wangting dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk AT madenseank dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk AT luebeckgeorge dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk AT lichristopheri dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk AT newcombpollya dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk AT ulrichcorneliam dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk AT joojihoone dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk AT buchanandanield dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk AT milnerogerl dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk AT southeymelissac dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk AT carterkellyt dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk AT willbanksamberr dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk AT luoyanxin dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk AT yuming dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk AT gradywilliamm dysfunctionalepigeneticagingofthenormalcolonandcolorectalcancerrisk |